{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T10:20:55Z","timestamp":1705486855535},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1001\/jamadermatol.2018.5379","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T14:35:47Z","timestamp":1548858947000},"page":"391","source":"Crossref","is-referenced-by-count":2,"title":["Decrease of Anti-DSG3, but Not Anti-DSG1 Antibody, After Cessation of Sitagliptin Treatment in a Patient With Pemphigus Vulgaris"],"prefix":"10.1001","volume":"155","author":[{"given":"Toshiya","family":"Handa","sequence":"first","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Sumikawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Minowa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Uhara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sapporo Medical University, Sapporo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"dlo180039r1","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1111\/jde.2018.45.issue-2","article-title":"Pemphigus vulgaris developing after 6-month treatment with a dipeptidyl peptidase-4 inhibitor: a case report.","volume":"45","author":"Okauchi","year":"2018","journal-title":"J Dermatol"},{"issue":"3","key":"dlo180039r2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/bjd.2014.171.issue-3","article-title":"Clinical and immunological profiles in 17 Japanese patients with drug-induced pemphigus studied at Kurume University.","volume":"171","author":"Yoshimura","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5","key":"dlo180039r3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors.","volume":"138","author":"Ujiie","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"16","key":"dlo180039r4","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1*0301 is present in clinical variants of pemphigoid.","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"dlo180039r5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10875-008-9244-x","article-title":"HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris.","volume":"29","author":"Shams","year":"2009","journal-title":"J Clin Immunol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamadermatology\/article-pdf\/155\/3\/391\/17393123\/jamadermatology_handa_2019_lo_180039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T12:33:26Z","timestamp":1552480406000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.5379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.5379","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}